- Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis
Farida Ahangari et al, 2022, American Journal of Respiratory and Critical Care Medicine CrossRef - Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors
Girieca Lorusso et al, 2020, Frontiers in Oncology CrossRef - Sorafenib combined with dasatinib therapy inhibits cell viability, migration, and angiogenesis synergistically in hepatocellular carcinoma
Chiung-Chi Cheng et al, 2021, Cancer Chemotherapy and Pharmacology CrossRef - Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification
Rong-Quan He et al, 2018, International Journal of Molecular Medicine CrossRef - Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities
Mohamed E. Shaker et al, 2023, International Immunopharmacology CrossRef - Kahweol Induces Apoptosis in Hepatocellular Carcinoma Cells by Inhibiting the Src/mTOR/STAT3 Signaling Pathway
Hye-Young Seo et al, 2021, International Journal of Molecular Sciences CrossRef - Prevalence, management and outcomes of pulmonary metastases in hepatocellular carcinoma: a systematic review and meta-analysis
Muhammad Emmamally et al, 2024, HPB CrossRef